4,6-Dichloropyrimidine → HCID 86663898, compound
Reaction equation
Cl[C:2]1[CH:7]=[C:6]([Cl:8])[N:5]=[CH:4][N:3]=1.[CH3:9][C:10]1[CH:11]=[C:12]([NH2:19])[CH:13]=[C:14]2[C:18]=1[NH:17][N:16]=[CH:15]2.CCN(C(C)C)C(C)C>CN(C=O)C>[Cl:8][C:6]1[N:5]=[CH:4][N:3]=[C:2]([NH:19][C:12]2[CH:13]=[C:14]3[C:18](=[C:10]([CH3:9])[CH:11]=2)[NH:17][N:16]=[CH:15]3)[CH:7]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
500 mg (3.40 mmol) 4,6-dichloropyrimidine, 500 mg (3.40 mmol) 7-methyl-1H-indazol-5-ylamine and 1.30 mL (7.60 mmol) DIPEA were combined in 5.0 mL DMF and refluxed for 5 h. The reaction mixture was cooled to RT and evaporated down i.vac. The residue was taken up in EtOAc and extracted several times with saturated sodium chloride solution. The organic phases were combined, dried on magnesium sulphate, filtered and evaporated down. The residue was stirred with DIPE, suction filtered and dried i. vac.
Workup
- temperaturerefluxed for 5 h
- customevaporated down i.vac
- extractionextracted several times with saturated sodium chloride solution
- customdried on magnesium sulphate
- filtrationfiltered
- customevaporated down
- filtrationfiltered
- customdried i
Sources & evidence
- ORD record
- ord-1e64719cac1841b6b97537087b54682b
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08952014B2
Reaction notes
Loading…